About X-Linked Agammaglobulinemia

Overview

X-linked agammaglobulinemia (XLA) is a primary immune deficiency disorder that weakens the immune system. XLA is passed down in families (inherited) and occurs almost always in males.

In XLA, the body can’t produce B cells, a type of white blood cell important for immunity. B cells make antibodies, also known as immunoglobulins, which help fight infections. However, individuals with XLA cannot make these antibodies because of genetic changes (mutations) in the BTK gene. As a results, their B cells do not mature correctly and can’t make antibodies.

People with XLA have very low levels of immunoglobulins, making them more likely to get infections. They often develop frequent and recurring bacterial infections starting around 6 months of age. Common infections include:

Pneumonia: A lung infection that makes breathing difficult
Bronchitis: Inflammation of the airways in the lungs
Middle ear infections: Infections in the ear that can cause pain and hearing problems
Conjunctivitis: Also known as pink eye, an infection that makes the eye red and itchy
Sinus infections: Infections in the spaces around the nose
Skin infections: Infections that can cause redness, pain, or swelling on the skin
Infections linked with chronic diarrhea: Intestinal infections that cause ongoing diarrhea

Children with XLA may initially be protected by antibodies acquired from their mother before birth. However, once these maternal antibodies are cleared from their body, they begin to experience recurrent infections. It's important to note that children with XLA may take longer to recover from infections and may experience repeated infections even while taking antibiotic medications.

XLA is inherited in an X-linked recessive way, meaning the gene mutation that causes the condition is located on the X chromosome. As a result, males are more commonly affected by XLA because they only have one X chromosome. Females typically carry the gene mutation but do not show symptoms because they have another X chromosome that can make up for the faulty gene.

Causes and Risk Factors

Causes of X-linked agammaglobulinemia:

XLA is caused by a mutation (changes) in a gene called Bruton tyrosine kinase (BTK), which is important for the proper development and function of B cells.
This mutation prevents the production of mature B lymphocytes, which are important for a healthy immune system.
Without functional B cells, individuals with XLA have a weakened immune response, making them more likely to get infections.

Non-modifiable risk factors (factors that cannot be changed or controlled) of XLA:

Gender: Since males have one X and one Y chromosome, they are more likely to be affected by XLA if they inherit the mutated gene.
Females with one copy of the mutated gene on one of their X chromosomes usually don’t have symptoms, but they can still pass it on to their children.

There are no known modifiable risk factors for developing XLA. It is mainly a genetic condition and cannot be prevented or influenced by lifestyle choices or environmental factors.

Symptoms

Common early symptoms of XLA include:

Recurrent sinus and lung infections: Patients with XLA often experience frequent respiratory infections, such as sinusitis (infection of the sinuses, which can cause stuffy nose and facial pain), bronchitis (inflammation of the airways in the lungs, leading to coughing and difficulty breathing), and pneumonia (a lung infection that makes it hard to breathe and can cause fever).
Gastrointestinal infections: XLA can also lead to recurrent gastrointestinal infections, which may cause symptoms like long-term (chronic) diarrhea.

As the disease progresses, symptoms of complications may occur. Complications may include:

Meningitis: Inflammation of the membranes surrounding the brain and spinal cord.
Sepsis: A life-threatening infection that can spread throughout the body.
Arthritis: Inflammation of the joints, which can cause pain, swelling, and stiffness.
Skin and soft tissue infections: XLA can make individuals more likely to develop skin infections like cellulitis (causes redness, swelling and pain) or abscesses (a collection of pus under the skin, which can be swollen and painful).
Enteroviral encephalitis: Infection and inflammation of the brain caused by enteroviruses.

It's important to note that the types and severity of symptoms can vary among individuals with XLA. If you suspect you or someone you know may have XLA, it is recommended to consult a healthcare professional for proper diagnosis and management.

Diagnosis

To diagnose XLA, healthcare providers may perform the following examinations, tests, and procedures:

Medical history: The doctor will ask about your symptoms and any previous diagnoses.
Physical exam: During a physical exam, the healthcare provider will look for signs of frequent infections or other symptoms that could indicate a weakened immune system.
Lab tests: Lab tests for diagnosing XLA usually involve checking a blood sample to measure antibody levels and to see if certain immune cells, called B cells, are missing.
Genetic testing: Genetic testing may be used to confirm XLA by checking for mutations in the BTK gene, which is responsible for the condition.
Imaging studies: Imaging studies may be recommended to check for complications from infections, but they are not usually needed to diagnose XLA. Imaging studies may be suggested to evaluate any changes in disease status or to monitor specific organs affected by XLA.

Additional clinical procedures may be performed based upon initial findings or individual factors, or to assess specific aspects related to disease progression or severity. These procedures can provide valuable information for determining appropriate management strategies.

Remember that coordination between patients, caregivers, and healthcare providers is essential for effective medical care. Good communication within your healthcare team can prevent unnecessary tests and lead to better outcomes. If you have any concerns about XLA or its diagnosis, it is best to consult with your healthcare provider for personalized advice and guidance.

Treatment Options

The goals of treatment for X-linked agammaglobulinemia (XLA) are to prevent secondary complications, improve clinical outcomes, and enhance overall health. Here are the different types of treatments and interventions recommended for XLA and how they work to achieve these goals:

Immunoglobulin replacement therapy: One of the main treatments for XLA is lifelong immunoglobulin replacement therapy. Immunoglobulins (IGs) are special proteins made by the immune system that help fight infections. People with XLA have very few B cells, which are responsible for producing these proteins. By receiving regular immunoglobulin infusions either through a vein (intravenously) or under the skin (subcutaneously), individuals with XLA can restore their low levels of IGs. This therapy helps prevent infections and improves overall health.
Prophylactic antibiotics: In some cases, prophylactic antibiotics may be recommended in addition to immunoglobulin replacement therapy. Prophylactic antibiotics are preventive antibiotics that are taken regularly to reduce the risk of bacterial infections. They work by killing or stopping the growth of bacteria in the body, thus preventing infections from occurring.
Early detection through newborn screening: Early detection of XLA and other severe B-cell deficiencies is important for starting treatment early and improving outcomes. Newborn screening programs can detect severe B-cell deficiencies by measuring kappa-deleting recombination excision circles (KRECs) in dried blood spots (DBS). KRECs serve as an indirect marker for the presence of B cells. By identifying affected infants early on, healthcare providers can start treatment promptly and prevent long-term complications.

It is important to note that these treatments can greatly improve the quality of life for individuals with XLA. Limited evidence shows a direct link between early diagnosis and reduced rates of illness and death in a large group of people with agammaglobulinemia.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.

Progression or Complications

Here's what happens over time and the common complications linked with X-linked agammaglobulinemia (XLA):

Natural progression:

XLA is typically diagnosed in early childhood, around 6 months of age.
Without treatment, people with XLA may experience recurrent bacterial infections throughout their lives.
The frequency and severity of infections can vary from person to person.
As individuals with XLA grow older, they may continue to be more likely to get infections.

Common complications:

People with XLA are prone to frequent and recurrent bacterial infections, particularly in the ears, throat, lungs, and sinuses.
Lung infections like pneumonia and bronchitis are commonly diagnosed in individuals with XLA.
Middle ear infections, conjunctivitis (pink eye), sinus infections, and various skin infections are also common complications.
Chronic diarrhea can be linked with infections in some cases.

It's important to note that while there are some home remedies or over-the-counter medications that may help manage symptoms or support overall health, it's crucial to consult a healthcare professional before trying any new treatments. They can provide personalized advice based on an individual's specific needs and medical history.